Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02043158 · ClinicalTrials.gov registry record
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
A clinical trial of Ovarian Cancer, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 240
- Enrollment target
- 5
- Study locations
NCT02043158: Active study of Ovarian Cancer, sponsored by M.D. Anderson Cancer Center.
NCT02043158 is a study of Ovarian Cancer that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 240 participants, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (67% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02043158, a study of Ovarian Cancer, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 240 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this research study is to learn about diet and exercise habits, emotions, and social support in the lives of women with ovarian cancer.
Primary Outcome
Biobehavioral information collected regarding social support, depressed mood, life stress, quality of life, meaning in life, socioeconomic and relationship status, and lifestyle factors such as exercise and diet, which have been linked with cancer progression and/or survival in cancer patients.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Interview
Study Locations (5)
California
- Cedars Sinai - West Hollywood
Iowa
- University of Iowa - Iowa City
New York
- Memorial Sloan Kettering - New York
Oklahoma
- University of Oklahoma - Norman
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2014-01-16 |
| Est. Completion | 2026-12-30 |
What the registry record for NCT02043158 still lists
NCT02043158 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 728-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.
NCT02043158 lists 5 locations in 5 states (California, Iowa, New York).
Frequently Asked Questions
What is clinical trial NCT02043158 about?
NCT02043158 is a clinical study titled "Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer". The goal of this research study is to learn about diet and exercise habits, emotions, and social support in the lives of women with ovarian cancer.
What is the current status of trial NCT02043158?
This trial is currently active not recruiting. The enrollment target is 240 participants. The study started on 2014-01-16. Estimated completion is 2026-12-30.
What conditions does trial NCT02043158 study?
This clinical trial studies the following conditions: Ovarian Cancer.
What interventions are being tested in trial NCT02043158?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT02043158?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02043158 being conducted?
This trial has 5 study locations across California, Iowa, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02043158's enrollment target sits among peer trials
240 83rd of 322 higher than 239 of 322 other Ovarian Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ovarian Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
RECRUITING
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI